Diabetes drug semaglutide offers hope beyond obesity management — kidney, heart & liver health
New Delhi: The blockbuster diabetes and obesity drug semaglutide, developed by Danish pharma giant Novo Nordisk, has already emerged as a favourite among affluent sections of society in India and …